期刊
STEROIDS
卷 76, 期 8, 页码 772-776出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.steroids.2011.02.035
关键词
Breast cancer; Oestrogen receptor; Endocrine resistance; Aromatase inhibitor; Kinases
资金
- Mary-Jean Mitchell Green Foundation
- Breakthrough Breast Cancer
- NHS
Aromatase inhibitors (AI) have improved the treatment of oestrogen receptor positive (ER+) breast cancer. Despite the efficacy of these agents over 40% of patients relapse with endocrine resistant disease. Here we describe an in vitro model of acquired resistance to long-term oestrogen deprivation (LTED). The LTED cells retain expression of the ER and appear hypersensitive to oestrogen as a result of altered kinase activity. Furthermore analysis of temporal changes in gene expression during the acquisition of resistance highlight growth factor receptor pathways as key mediators of this adaptive process. (C) 2011 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据